Navigation Links
UV-based Air Purification, A New Way To Fight The Flu
Date:2/12/2013

CENTERVILLE, Mass., Feb 12, 2013 /PRNewswire/ -- UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company") announced today there is good news for those living in the 47 states that are reporting widespread flu activity. UVFLU has developed the only pure UV based, FDA-cleared, class 2 medical device for fighting airborne infection and is now offering it to consumers. The Company has spent millions of dollars developing this unit and in the past has sold the unit mostly to hospitals and other medical facilities.

The Company has just launched a Groupon with special pricing during the current flu outbreak, which can be taken advantage of by visiting http://www.groupon.com/deals/gg-air-purification-system  We felt Groupon was the perfect Company to help with the consumer launch given their huge marketing and logistics capability. 

The Viratech UV-400 is an FDA Cleared Class II Medical Device for killing over 99% of airborne bacteria, along with a host of other contaminants, including odors, smoke, and toxic chemicals, with every pass, in rooms up to 800 sq. feet. The device is unique in that it uses germicidal ultra violet light to actually kill organic contaminants, versus typical air purifiers which only "trap" contaminants.

This year's flu season is now in full swing and hitting earlier and stronger than anytime in the past decade, according to the Centers for Disease Control and Prevention (CDC)." Reports of Influenza-like-illness (ILI), are nearing what have been peak levels during moderately severe seasons, according to Dr. Joe Bresee , Chief of Epidemiology and Prevention Branch in CDC's Influenza Division. "While influenza vaccination offers the best protection we have against influenza, it's still possible that some people may become ill despite being vaccinated."

People who are most susceptible to flu complications include young children, people sixty-five and older, pregnant women and those with underlying medical conditions. While everyone should take extra precautions this time of year, these groups are urged to take simple, additional steps to remove or kill contaminated air before they breathe it in. Flu viruses can be transmitted from coughs and sneezes up to 6 feet away, and the average person breathes 3600 gallons of air per day, so indoor air quality is essential.

Germicidal UV light has been found to be one of the most effective methods of killing both airborne and surface contamination, caused by bacteria and viruses. Hospitals routinely use ultraviolet light to kill bacteria and viruses on surfaces, and in the air. UV Flu Technology has developed residential, air purifiers that utilize this hospital-grade method. 

"This serious outbreak may only be the beginning of a host of airborne diseases becoming major headlines over the next several years," said Jack Lennon , President of UV Flu Technologies. "Flu, Whooping Cough, TB, MRSA, Staph, and a host of other airborne transmitted diseases are coming back, many of which have grown resistant to treatments using antibiotics. The extensive use of antibiotics over the last few decades have contributed to lower immune response systems in many Americans. Children, seniors, and anyone undergoing transplants, or other medical treatments, which lower the immune response, are at serious risk of getting potentially fatal bacterial infections. The strain of Tuberculosis now appearing in India and Eastern Europe is now infecting millions of people, with fatality rates sometimes exceeding 50%," said Mr. Lennon. "Although, on average, 36,000 people die from flu-like symptoms annually in this country, many times more die from bacterial infections, and up to 500,000 may die from diseases related to cardiopulmonary diseases related to indoor air pollution."

Anybody interested in learning more about how UVFLU's technology can call the company TOLL FREE at (877)-FLU-KILL - (877) 358-5455.

About UV Flu Technologies, Inc. 
UV Flu Technologies is an innovative developer; manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector ($7 billion in 2011). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: http://uvflutech.com/.


'/>"/>
SOURCE UV Flu Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. High Voltage Power Supply Manufacturer Holds Annual Food Drive to Fight Local Hunger
2. Natural Solutions to Fight Depression and Anxiety During the Holiday Season
3. Queens Volunteer Firefighters Receive Mold Removal Training; IgotMold Recommends Use of Molderizer to Make the Process Effective and Safe
4. X-ray laser helps fight sleeping sickness
5. Fighting bacteria with mucus
6. Can Cannabidiol (CBD) Fight Metastatic Cancer? According to the latest research the answer is yes.
7. Sabiya Donates Odor-Fighting Athletic Apparel to the Corps of Exploration Aboard E/V Nautilus
8. Bed Bugs Bite on Businesses, Green Bean Buddy Advises Owners to Fight Back With a Non-Toxic Bed Bug Bully Product
9. Nanosurgery and the fight against cancer: Major breakthrough at Polytechnique Montral
10. MU researchers identify key plant immune response in fight against bacteria
11. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... PARK, Calif. , Feb. 4, 2016   DelMar ... biopharmaceutical company focused on the development and commercialization of new ... 18 th Annual BIO CEO & Investor Conference ... in New York, NY . ... an update on the ongoing clinical trial of VAL-083 ...
(Date:2/4/2016)... 4, 2016 Sinovac Biotech Ltd. ("Sinovac" or ... of biopharmaceutical products in China , ... of directors received on February 4, 2016 a preliminary ... consortium comprised of PKU V-Ming ( Shanghai ... CICC Qianhai Development ( Shenzhen ) Fund ...
(Date:2/3/2016)... DIEGO , Feb. 3, 2016   ... company with the first pluripotent stem cell-derived islet ... diabetes in clinical-stage development, today announced that ViaCyte ... Pharmaceutical Companies of Johnson & Johnson, have agreed ... group into ViaCyte.  The agreement provides ViaCyte with ...
(Date:2/3/2016)... NEW YORK and HOLLISTON, Mass., Feb. 3, ... (Nasdaq: HART ), a biotechnology company developing ... esophagus, trachea and bronchus, today announced that CEO ... BIO CEO & Investor Conference on ... in New York City . ...
Breaking Biology Technology:
(Date:1/22/2016)... , January 22, 2016 ... the addition of the  "Global Behavioral ... offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ... "Global Behavioral Biometric Market 2016-2020"  report ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ...
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
(Date:1/13/2016)... --> --> ... report titled - Biometric Sensors Market - Global Industry Analysis, ... to the report, the global biometric sensors market was valued at ... US$1,625.8 mn by 2023, expanding at a CAGR of ... the biometric sensors market is expected to reach 1,799.6 ...
Breaking Biology News(10 mins):